- Joined
- Jan 3, 2014
- Messages
- 5
- Reaction score
- 1
Hi all,
What is the reason that IGRT is not employed more often for soft-tissue tumours? Reasons I can think of are extra cost/time and lack of evidence that it is really necessary for more routine RT plans. Am I right or is there more to it?
What is the reason that IGRT is not employed more often for soft-tissue tumours? Reasons I can think of are extra cost/time and lack of evidence that it is really necessary for more routine RT plans. Am I right or is there more to it?
Last edited: